96K-10657-83474
4 vaccinations
9 coded responses
46 check-ins
9 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 805 / CO
- Registered
- 2021-02-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-27
Registered in v-safe
-
2021-02-27
Dose 1 — Moderna
- 2021-02-27
- 2021-02-28
- 2021-03-01
-
2021-03-02
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: GoodFree text: runny nose part of the day - mildMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
- 2021-03-04
- 2021-03-06
- 2021-03-13
- 2021-03-21
-
2021-03-27
Dose 2 — Moderna
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-10
-
2021-04-18
Survey response — day 21, dose 2MedDRA: Vertigo — Feeling: Good · Be unable to do your normal daily activitiesFree text: I've had daily mild and moderate spells of vertigo for a week.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-24
- 2021-05-01
-
2021-05-08
Survey response — day 42, dose 2MedDRA: Vertigo — Feeling: GoodFree text: Vertigo intermittently every day. Not debilitating. Still able to do daily activities.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-26
-
2021-10-23
Dose 3 — Moderna
-
2021-10-27
Survey response — days 1–6 daily, dose 3MedDRA: Chills, Fatigue, Headache — Feeling: GoodFree text: following booster on 10/23/2021 had fatigue, headache and chills that resolved in 36 hoursMedDRA releases: 2024-11 · check-in free text available
- 2021-10-28
- 2021-10-30
- 2021-11-06
- 2021-11-13
- 2021-11-20
- 2021-11-27
- 2021-12-04
- 2022-01-22
-
2022-04-14
Dose 4 — Moderna
-
2022-04-15
Survey response — days 1–6 daily, dose 4MedDRA: Nasal congestion — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: minor nasal congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-04-16
Survey response — days 1–6 daily, dose 4MedDRA: Nausea — Feeling: Fair · NauseaFree text: 3-4 hrs of feeling nauseous overnight; less intense as the day progressedMedDRA releases: 2024-11 · check-in free text available
- 2022-04-17
- 2022-04-18
- 2022-04-19
-
2022-04-20
Survey response — days 1–6 daily, dose 4MedDRA: Exposure to SARS-CoV-2 — Feeling: FairFree text: Was exposed yesterday to Covid positive person. Will test myself 4/22 - 4/26 or when symptomaticMedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Survey response — day 7, dose 4MedDRA: Exposure to SARS-CoV-2, Rhinorrhoea, SARS-CoV-2 test negative, Sneezing — Feeling: FairFree text: Exposed to Covid positive person 4/19. Self-test 4/22 was negative. Will test again 4/23. Minor symptoms. Drippy nose, sneezing. Breathing is fine.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-28
- 2022-05-05
- 2022-05-12
- 2022-05-19
- 2022-05-26
- 2022-07-14
-
2022-10-13
Survey response — 6 months, dose 4MedDRA: COVID-19, Malaise — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Positive Covid-19 on 7/25/2022 Prescribed and completed 5 day course of Paxlovid; symptoms returned after treatment; remained ill for another 10 daysMedDRA releases: 2024-11 · check-in free text available
-
2022-10-13
Report sent to call center — 6 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-14
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-27 | Moderna | |
| 2 | 2021-03-27 | Moderna | |
| 3 | 2021-10-23 | Moderna | No |
| 4 | 2022-04-14 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): runny nose part of the day - mild
Release 7 — day 21, dose 2
Symptoms: I've had daily mild and moderate spells of vertigo for a week.
Release 8 — day 42, dose 2
Symptoms: Vertigo intermittently every day. Not debilitating. Still able to do daily activities.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): following booster on 10/23/2021 had fatigue, headache and chills that resolved in 36 hours
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): minor nasal congestion
Systemic reaction (other): 3-4 hrs of feeling nauseous overnight; less intense as the day progressed
Systemic reaction (other): Was exposed yesterday to Covid positive person. Will test myself 4/22 - 4/26 or when symptomatic
Release 11 — day 7, dose 4
Systemic reaction (other): Exposed to Covid positive person 4/19. Self-test 4/22 was negative. Will test again 4/23. Minor symptoms. Drippy nose, sneezing. Breathing is fine.
Release 12 — 6 months, dose 4
Symptoms: Positive Covid-19 on 7/25/2022 Prescribed and completed 5 day course of Paxlovid; symptoms returned after treatment; remained ill for another 10 days
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Vertigo | ✓ | ✓ | ✓ |
| SRO | Chills | · | · | ✓ |
| SRO | Exposure to SARS-CoV-2 | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Nausea | · | · | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release